Subclinical Atherosclerosis in Rheumatoid Arthritis and Systemic Lupus Erythematosus

American Journal of Medicine

Volumn 121, Issue 10 SUPPL.1, 2008, Pages

  Salmon, Jane E ^a,b   Roman, Mary J ^b  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Atherosclerosis; Cardiovascular disease; Cardiovascular mortality; Rheumatoid arthritis

Indexed keywords

GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ACUTE HEART INFARCTION; AGE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISEASE DURATION; ECHOGRAPHY; HUMAN; MONOTHERAPY; MORBIDITY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; CAROTID ARTERIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MORBIDITY; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 52949103244     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2008.06.010     Document Type: Article

References (56)

1. Gabriel S.E., Crowson C.S., Kremers H.M., et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum 48 (2003) 54-58
2. Doria A., Iaccarino L., Ghirardello A., et al. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 119 (2006) 700-706
3. Wolfe F., Mitchell D.M., Sibley J.T., et al. The mortality of rheumatoid arthritis. Arthritis Rheum 37 (1994) 481-494
4. Manzi S., Meilahn E.N., Rairie J.E., et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 145 (1997) 408-415
5. Jacobsson L.T., Knowler W.C., Pillemer S., et al. Rheumatoid arthritis and mortality: a longitudinal study in Pima Indians. Arthritis Rheum 36 (1993) 1045-1053
6. Wallberg-Jonsson S., Ohman M.L., and Dahlqvist S.R. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol 24 (1997) 445-451
7. Gonzalez-Gay M.A., Gonzalez-Juanatey C., and Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 35 (2005) 8-17
8. Turesson C., and Matteson E.L. Cardiovascular risk factors, fitness and physical activity in rheumatic diseases. Curr Opin Rheumatol 19 (2007) 190-196
9. Maradit-Kremers H., Nicola P.J., Crowson C.S., Ballman K.V., and Gabriel S.E. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52 (2005) 722-732
10. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
11. Watson D.J., Rhodes T., and Guess H.A. All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. J Rheumatol 30 (2003) 1196-1202
12. Goodson N.J., Wiles N.J., Lunt M., et al. Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum 46 (2002) 2010-2019
13. Edwards C.J., Syddall H., Goswami R., et al. Rheumatoid factor may be an Independent risk factor for ischaemic heart disease. Heart 93 (2007) 1263-1267
14. Solomon D.H., Karlson E.W., Rimm E.B., et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107 (2003) 1303-1307
15. Fischer L.M., Schlienger R.G., Matter C., Jick H., and Meier C.R. Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am J Cardiol 93 (2004) 198-200
16. del Rincón I.D., Williams K., Stern M.P., Freeman G.L., and Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44 (2001) 2737-2745
17. Ward M.M. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 42 (1999) 338-346
18. Esdaile J.M., Abrahamowicz M., Grodzicky T., et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44 (2001) 2331-2337
19. Turesson C., McClelland R.L., Christianson T.J., and Matteson E.L. Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis 66 (2007) 70-75
20. Choi H.K., Hernán M.A., Seeger J.D., Robins J.M., and Wolfe F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359 (2002) 1173-1177
21. Krishnan E., Lingala V.B., and Singh G. Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis. Circulation 110 (2004) 1774-1779
22. Jacobsson L.T., Turesson C., Gulfe A., et al. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol 32 (2005) 1213-1218
23. Solomon D.H., Avorn J., Katz J.N., et al. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum 54 (2006) 3790-3798
24. Khoury Z., Schwartz R., Gottlieb S., Chenzbraun A., Stern S., and Keren A. Relation of coronary artery disease to atherosclerotic disease in the aorta, carotid, and femoral arteries evaluated by ultrasound. Am J Cardiol 80 (1997) 1429-1433
25. Roman M.J., Naqvi T.Z., Gardin J.M., et al. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology. J Am Soc Echocardiogr 19 (2006) 943-954
26. Brohall G., Odén A., and Fagerberg B. Carotid artery intima-media thickness in patients with Type 2 diabetes mellitus and impaired glucose tolerance: a systematic review. Diabet Med 23 (2006) 609-616
27. Lavrencic A., Kosmina B., Keber I., Videcnik V., and Keber D. Carotid intima-media thickness in young patients with familial hypercholesterolaemia. Heart 76 (1996) 321-325
28. Magyar M.T., Paragh G., Katona E., et al. Serum cholesterols have a more important role than triglycerides in determining intima-media thickness of the common carotid artery in subjects younger than 55 years of age. J Ultrasound Med 23 (2004) 1161-1169
29. Pujia A., Gnasso A., Irace C., et al. Intimal plus media thickness of common carotid arterial wall in subjects with hypertension. Artery 21 (1994) 222-233
30. Arnett D.K., Tyroler H.A., Burke G., Hutchinson R., Howard G., and Heiss G. Hypertension and subclinical carotid artery atherosclerosis in blacks and whites. The Atherosclerosis Risk in Communities Study. ARIC Investigators. Arch Intern Med 156 (1996) 1983-1989
31. Cuspidi C., Mancia G., Ambrosioni E., et al. Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS). J Hum Hypertens 18 (2004) 891-896
32. Su T.C., Lee Y.T., Chou S., Hwang W.T., Chen C.F., and Wang J.D. Twenty-four-hour ambulatory blood pressure and duration of hypertension as major determinants for intima-media thickness and atherosclerosis of carotid arteries. Atherosclerosis 184 (2006) 151-156
33. Belcaro G., Nicolaides A.N., Laurora G., et al. Ultrasound morphology classification of the arterial wall and cardiovascular events in a 6-year follow-up study. Arterioscler Thromb Vasc Biol 16 (1996) 851-856
34. Iglesias del Sol A., Moons K.G., Hollander M., et al. Is carotid intima-media thickness useful in cardiovascular disease risk assessment?. The Rotterdam Study. Stroke 32 (2001) 1532-1538
35. Chambless L.E., Heiss G., Folsom A.R., et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 146 (1997) 483-494
36. Roman M.J., Shanker B.A., Davis A., et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 349 (2003) 2399-2406
37. Manzi S., Selzer F., Sutton-Tyrrell K., et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 42 (1999) 51-60
38. Kumeda Y., Inaba M., Goto H., et al. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 46 (2002) 1489-1497
39. Park Y.B., Ahn C.W., Choi H.K., et al. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum 46 (2002) 1714-1719
40. Surdacki A., Martens-Lobenhoffer J., Wloch A., et al. Elevated plasma asymmetric dimethyl-l-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis. Arthritis Rheum 56 (2007) 809-819
41. del Rincón I., Williams K., Stern M.P., et al. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 48 (2003) 1833-1840
42. Chung C.P., Oeser A., Raggi P., et al. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum 52 (2005) 3045-3053
43. del Rincón I., Freeman G.L., Haas R.W., O'Leary D.H., and Escalante A. Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum 52 (2005) 3413-3423
44. del Rincón I., O'Leary D.H., Freeman G.L., and Escalante A. Acceleration of atherosclerosis during the course of rheumatoid arthritis. Atherosclerosis 195 (2007) 354-360
45. Farragher T.M., Goodson N.J., Naseem H., et al. Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis Rheum 58 (2008) 359-369
46. Wattanakit K., Folsom A.R., Chambless L.E., and Nieto F.J. Risk factors for cardiovascular event recurrence in the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 149 (2005) 606-612
47. Bonithon-Kopp C., Touboul P.J., Berr C., et al. Relation of intima-media thickness to atherosclerotic plaques in carotid arteries: the Vascular Aging (EVA) Study. Arterioscler Thromb Vasc Biol 16 (1996) 310-316
48. Wyman R.A., Fraizer M.C., Keevil J.G., et al. Ultrasound-detected carotid plaque as a screening tool for advanced subclinical atherosclerosis. Am Heart J 150 (2005) 1081-1085
49. Zureik M., Ducimetiere P., Touboul P.J., et al. Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol 20 (2000) 1622-1629
50. Roman M.J., Devereux R.B., Schwartz J.E., et al. Arterial stiffness in chronic inflammatory diseases. Hypertension 46 (2005) 194-199
51. Roman M.J., Moeller E., Davis A., et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med 144 (2006) 249-256
52. Wyman R.A., Mays M.E., McBride P.E., and Stein J.H. Ultrasound-detected carotid plaque as a predictor of cardiovascular events. Vasc Med 11 (2006) 123-130
53. Belcaro G., Nicolaides A.N., Ramaswami G., et al. Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study). Atherosclerosis 156 (2001) 379-387
54. Salonen J.T., and Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 87 (1993) II56-II65
55. Pham T., Gossec L., Constantin A., et al. Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. Joint Bone Spine 73 (2006) 379-387
56. Furst D.E., Halbert R.J., Bingham III C.O., et al. Evaluating the adequacy of disease control in patients with rheumatoid arthritis: a RAND appropriateness panel. Rheumatol 47 (2008) 194-199